Global and United States Osteoarthritis Medications Market Report & Forecast 2022-2028

List of Figures, Tables and Charts Available in Global and United States Osteoarthritis Medications Market Report & Forecast 2022-2028

List of Tables
Table 1. Osteoarthritis Medications Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Osteoarthritis Medications Market Trends
Table 3. Osteoarthritis Medications Market Drivers
Table 4. Osteoarthritis Medications Market Challenges
Table 5. Osteoarthritis Medications Market Restraints
Table 6. Global Osteoarthritis Medications Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Osteoarthritis Medications Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Osteoarthritis Medications Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Osteoarthritis Medications Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Osteoarthritis Medications Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Osteoarthritis Medications Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Osteoarthritis Medications Revenue Share by Player, 2017-2022
Table 13. Global Osteoarthritis Medications Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osteoarthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2021)
Table 15. Top Players of Osteoarthritis Medications in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Osteoarthritis Medications Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Osteoarthritis Medications Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Osteoarthritis Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Osteoarthritis Medications Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Osteoarthritis Medications Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Osteoarthritis Medications Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Osteoarthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Osteoarthritis Medications Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Osteoarthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Osteoarthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Osteoarthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Osteoarthritis Medications Product
Table 33. Pfizer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Johnson & Johnson Company Details
Table 36. Johnson & Johnson Business Overview
Table 37. Johnson & Johnson Osteoarthritis Medications Product
Table 38. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 39. Johnson & Johnson Recent Development
Table 40. GlaxoSmithKline Company Details
Table 41. GlaxoSmithKline Business Overview
Table 42. GlaxoSmithKline Osteoarthritis Medications Product
Table 43. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 44. GlaxoSmithKline Recent Development
Table 45. Novartis Company Details
Table 46. Novartis Business Overview
Table 47. Novartis Osteoarthritis Medications Product
Table 48. Novartis Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 49. Novartis Recent Development
Table 50. Bayer Company Details
Table 51. Bayer Business Overview
Table 52. Bayer Osteoarthritis Medications Product
Table 53. Bayer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. Eli Lilly Company Details
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Osteoarthritis Medications Product
Table 58. Eli Lilly Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. Sanofi Company Details
Table 61. Sanofi Business Overview
Table 62. Sanofi Osteoarthritis Medications Product
Table 63. Sanofi Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 64. Sanofi Recent Development
Table 65. Horizon Pharma Company Details
Table 66. Horizon Pharma Business Overview
Table 67. Horizon Pharma Osteoarthritis Medications Product
Table 68. Horizon Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 69. Horizon Pharma Recent Development
Table 70. Abbott Company Details
Table 71. Abbott Business Overview
Table 72. Abbott Osteoarthritis Medications Product
Table 73. Abbott Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 74. Abbott Recent Development
Table 75. Mylan Company Details
Table 76. Mylan Business Overview
Table 77. Mylan Osteoarthritis Medications Product
Table 78. Mylan Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 79. Mylan Recent Development
Table 80. Daiichi Sankyo Company Details
Table 81. Daiichi Sankyo Business Overview
Table 82. Daiichi Sankyo Osteoarthritis Medications Product
Table 83. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 84. Daiichi Sankyo Recent Development
Table 85. TEVA Company Details
Table 86. TEVA Business Overview
Table 87. TEVA Osteoarthritis Medications Product
Table 88. TEVA Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 89. TEVA Recent Development
Table 90. Almatica Pharma Company Details
Table 91. Almatica Pharma Business Overview
Table 92. Almatica Pharma Osteoarthritis Medications Product
Table 93. Almatica Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 94. Almatica Pharma Recent Development
Table 95. Astellas Pharma Company Details
Table 96. Astellas Pharma Business Overview
Table 97. Astellas Pharma Osteoarthritis Medications Product
Table 98. Astellas Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 99. Astellas Pharma Recent Development
Table 100. Tide Pharmaceutical Company Details
Table 101. Tide Pharmaceutical Business Overview
Table 102. Tide Pharmaceutical Osteoarthritis Medications Product
Table 103. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 104. Tide Pharmaceutical Recent Development
Table 105. Iroko Pharmaceuticals Company Details
Table 106. Iroko Pharmaceuticals Business Overview
Table 107. Iroko Pharmaceuticals Osteoarthritis Medications Product
Table 108. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 109. Iroko Pharmaceuticals Recent Development
Table 110. Hengrui Pharmaceutical Company Details
Table 111. Hengrui Pharmaceutical Business Overview
Table 112. Hengrui Pharmaceutical Osteoarthritis Medications Product
Table 113. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 114. Hengrui Pharmaceutical Recent Development
Table 115. Abiogen Pharma Company Details
Table 116. Abiogen Pharma Business Overview
Table 117. Abiogen Pharma Osteoarthritis Medications Product
Table 118. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 119. Abiogen Pharma Recent Development
Table 120. Flexion Therapeutics Company Details
Table 121. Flexion Therapeutics Business Overview
Table 122. Flexion Therapeutics Osteoarthritis Medications Product
Table 123. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 124. Flexion Therapeutics Recent Development
Table 125. Anika Therapeutics Company Details
Table 126. Anika Therapeutics Business Overview
Table 127. Anika Therapeutics Osteoarthritis Medications Product
Table 128. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
Table 129. Anika Therapeutics Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoarthritis Medications Product Picture
Figure 2. Global Osteoarthritis Medications Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Osteoarthritis Medications Market Size 2017-2028 (US$ Million)
Figure 4. United States Osteoarthritis Medications Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Osteoarthritis Medications Market Size 2017-2028 (US$ Million)
Figure 6. United States Osteoarthritis Medications Market Share in Global 2017-2028
Figure 7. Osteoarthritis Medications Report Years Considered
Figure 8. Product Picture of NSAIDs
Figure 9. Product Picture of Corticosteroids
Figure 10. Product Picture of Hyaluronic Acid Injection
Figure 11. Product Picture of Others
Figure 12. Global Osteoarthritis Medications Market Share by Type in 2022 & 2028
Figure 13. Global Osteoarthritis Medications Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Osteoarthritis Medications Market Share by Type (2017-2028)
Figure 15. United States Osteoarthritis Medications Market Share by Type in 2022 & 2028
Figure 16. United States Osteoarthritis Medications Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Osteoarthritis Medications Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospital Pharmacies
Figure 19. Product Picture of Retail Pharmacies
Figure 20. Product Picture of Online Pharmacies
Figure 21. Global Osteoarthritis Medications Market Share by Application in 2022 & 2028
Figure 22. Global Osteoarthritis Medications Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Osteoarthritis Medications Market Share by Application (2017-2028)
Figure 24. United States Osteoarthritis Medications Market Share by Application in 2022 & 2028
Figure 25. United States Osteoarthritis Medications Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Osteoarthritis Medications Market Share by Application (2017-2028)
Figure 27. North America Osteoarthritis Medications Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. United States Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Osteoarthritis Medications Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Osteoarthritis Medications Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. China Taiwan Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Osteoarthritis Medications Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Osteoarthritis Medications Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UAE Osteoarthritis Medications Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 55. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 58. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 61. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 62. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 63. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 65. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 66. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 67. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 68. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 69. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 70. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 71. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 72. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 73. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Keyplayers in Global and United States Osteoarthritis Medications Market Report & Forecast 2022-2028

Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics